EBR · ASX

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:EBR)

AU$1.05

 0.0 (0.0%)
ASX:Live
15/10/2024 04:10:23 PM
Volume Spike Hammer Bearish HALO Price Momentum HALO Ords HALO Momentum +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EBR Overview

EBR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Neutral

About EBR

Website

N/A

Telephone

1.408.720.1906

Address

480 Oakmead Parkway Sunnyvale, CA 94085

Description

N/A

EBR Price Chart

Key Stats

Market Cap

AU$346.25M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.53 - 1.23

Trade Value (12mth)

US$26,908.00

1 week

7.69%

1 month

11.37%

YTD

64.03%

1 year

47.97%

All time high

1.34

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

-$33m

Free Cash Flow Return

-48.70%

ROIC

-52.20%

Interest Coverage

-7.50

Quick Ratio

11.50

Other Data

Shares on Issue (Fully Dilluted)

310m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.03

EBR Announcements

Latest Announcements

Date Announcements

14 October 24

Completion of Retail Entitlement Offer

×

Completion of Retail Entitlement Offer

02 October 24

Granting of ASX waiver U.S. Financial Reporting Requirements

×

Granting of ASX waiver U.S. Financial Reporting Requirements

30 September 24

FDA commences substantive review of EBR PMA application

×

FDA commences substantive review of EBR PMA application

26 September 24

Cleansing Notice

×

Cleansing Notice

25 September 24

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

24 September 24

Retail Entitlement Offer Booklet

×

Retail Entitlement Offer Booklet

24 September 24

Notification to Eligible Securityholder Letter

×

Notification to Eligible Securityholder Letter

24 September 24

Notification to Ineligible Securityholder Letter

×

Notification to Ineligible Securityholder Letter

20 September 24

EBR Placement and Institutional Entitlement Offer Completed

×

EBR Placement and Institutional Entitlement Offer Completed

19 September 24

Amendment to Form 10

×

Amendment to Form 10

18 September 24

Trading Halt

×

Trading Halt

18 September 24

EBR Systems announces a A$50m capital raising

×

EBR Systems announces a A$50m capital raising

18 September 24

EBR Cleansing Notice

×

EBR Cleansing Notice

18 September 24

Capital Raising Investor Presentation

×

Capital Raising Investor Presentation

18 September 24

Proposed issue of securities - EBR

×

Proposed issue of securities - EBR

16 September 24

EBR Systems Investor Roadshow

×

EBR Systems Investor Roadshow

11 September 24

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

10 September 24

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

29 August 24

EBR submits final PMA module to the U.S. FDA

×

EBR submits final PMA module to the U.S. FDA

27 August 24

Appendix 4D and Half Year Report & Accounts

×

Appendix 4D and Half Year Report & Accounts

27 August 24

EBR Half Year Results 2024 and Securityholder Update

×

EBR Half Year Results 2024 and Securityholder Update

14 August 24

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

13 August 24

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

12 August 24

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

01 August 24

Pivotal SOLVE-CRT Study Results Published in JAMA Cardiology

×

Pivotal SOLVE-CRT Study Results Published in JAMA Cardiology

EBR Fundamentals

Per Share Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.94 -0.12 -0.12 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.94 -0.12 -0.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 87.0 1.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.09 -0.12 -0.11 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.54 -0.11 -0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 94.7 -34.1 6.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -87.9 -36.2 -28.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.28 0.16 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.28 0.16 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 109.9 -42.7 -37.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 42 272 291 Lock Lock Lock
Basic m Lock Lock Lock Lock 42 272 291 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 22 33 34 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.9 -69.9 -15.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -22 -33 -34 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.1 -46.8 -2.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -23 -34 -35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.7 -47.2 -3.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -40 -33 -35 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -40 -33 -35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -54.9 16.9 -5.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -22 -30 -33 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -49 -9 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 96 17 40 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -23 -31 -33 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.5 -34.8 -6.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 78 64 72 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 85 72 79 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 21 41 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -73 -42 -31 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 10 28 48 Lock Lock Lock
Equity $m Lock Lock Lock Lock 78 45 30 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 78 65 72 Lock Lock Lock
     Growth % Lock Lock Lock Lock 399.2 -16.4 10.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -46.6 -46.2 -44.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -57.6 -46.6 -51.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -144.2 -46.9 -52.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -80.2 -43.0 -48.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -1.2 -21.5 -7.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.3 1.3 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.7 -93.4 -101.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.1 11.2 11.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 11.1 11.2 11.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 96.5 95.4 97.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -302.8 -511.9 -507.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -46.6 -46.2 -44.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.6 2.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 839.3 1,054.6 934.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -839.3 -1,054.6 -934.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.03%

Value ($M)

0

Prior Change

N/A

7 Day Change

-0.10%

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EBR Shortsell

Frequently Asked Questions

The current share price of EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$1.05.
The 52-week high share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$1.23.
The 52-week low share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX)? is AU$0.53.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) has a franking level of 0.0%.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is classified in the Healthcare.
The current P/E ratio for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.